Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression: a prospective cohort study.
Savoldi A, Morra M, De Nardo P, Cattelan AM, Mirandola M, Manfrin V, Scotton P, Giordani MT, Brollo L, Panese S, Lanzafame M, Scroccaro G, Berkell M, Lippi G, Konnova A, Smet M, Malhotra-Kumar S, Kumar-Singh S, Tacconelli E; mAb Working Group. Savoldi A, et al. Among authors: mirandola m. Eur J Clin Microbiol Infect Dis. 2022 Jul;41(7):1065-1076. doi: 10.1007/s10096-022-04464-x. Epub 2022 Jun 21. Eur J Clin Microbiol Infect Dis. 2022. PMID: 35727429 Free PMC article.
Long-Term Patient-Centred Follow-up in a Prospective Cohort of Patients with COVID-19.
Righi E, Mirandola M, Mazzaferri F, Razzaboni E, Zaffagnini A, Erbogasto A, Vecchia ID, Auerbach N, Ivaldi F, Mongardi M, Minuz P, Milella M, Mehrabi S, Olivieri O, Girelli D, Polati E, Micheletto C, Tacconelli E. Righi E, et al. Among authors: mirandola m. Infect Dis Ther. 2021 Sep;10(3):1579-1590. doi: 10.1007/s40121-021-00461-3. Epub 2021 Jun 21. Infect Dis Ther. 2021. PMID: 34152573 Free PMC article.
Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort study.
Righi E, Mirandola M, Mazzaferri F, Dossi G, Razzaboni E, Zaffagnini A, Ivaldi F, Visentin A, Lambertenghi L, Arena C, Micheletto C, Gibellini D, Tacconelli E. Righi E, et al. Among authors: mirandola m. J Infect. 2022 Apr;84(4):566-572. doi: 10.1016/j.jinf.2022.02.003. Epub 2022 Feb 10. J Infect. 2022. PMID: 35150765 Free PMC article.
Clinical Impact of Monoclonal Antibodies in the Treatment of High-Risk Patients with SARS-CoV-2 Breakthrough Infections: The ORCHESTRA Prospective Cohort Study.
Savoldi A, Morra M, Castelli A, Mirandola M, Berkell M, Smet M, Konnova A, Rossi E, Cataudella S, De Nardo P, Gentilotti E, Gupta A, Fasan D, Gibbin E, Cioli Puviani F, Hasenauer J, Gusinow R, Tami A, Kumar-Singh S, Malhotra-Kumar S, mAb Orchestra Working Group, Tacconelli E. Savoldi A, et al. Among authors: mirandola m. Biomedicines. 2022 Aug 24;10(9):2063. doi: 10.3390/biomedicines10092063. Biomedicines. 2022. PMID: 36140162 Free PMC article.
Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern.
Mazzaferri F, Mirandola M, Savoldi A, De Nardo P, Morra M, Tebon M, Armellini M, De Luca G, Calandrino L, Sasset L, D'Elia D, Sozio E, Danese E, Gibellini D, Monne I, Scroccaro G, Magrini N, Cattelan A, Tascini C; MANTICO Working Group; Tacconelli E. Mazzaferri F, et al. Among authors: mirandola m. Elife. 2022 Nov 22;11:e79639. doi: 10.7554/eLife.79639. Elife. 2022. PMID: 36413383 Free PMC article. Clinical Trial.
Mycoplasma genitalium antibiotic resistance-associated mutations in genital and extragenital samples from men-who-have-sex-with-men attending a STI clinic in Verona, Italy.
Sandri A, Carelli M, Visentin A, Savoldi A, De Grandi G, Mirandola M, Lleo MM, Signoretto C, Cordioli M. Sandri A, et al. Among authors: mirandola m. Front Cell Infect Microbiol. 2023 Mar 31;13:1155451. doi: 10.3389/fcimb.2023.1155451. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37065200 Free PMC article.
How European Research Projects Can Support Vaccination Strategies: The Case of the ORCHESTRA Project for SARS-CoV-2.
Azzini AM, Canziani LM, Davis RJ, Mirandola M, Hoelscher M, Meyer L, Laouénan C, Giannella M, Rodríguez-Baño J, Boffetta P, Mates D, Malhotra-Kumar S, Scipione G, Stellmach C, Rinaldi E, Hasenauer J, Tacconelli E. Azzini AM, et al. Among authors: mirandola m. Vaccines (Basel). 2023 Aug 14;11(8):1361. doi: 10.3390/vaccines11081361. Vaccines (Basel). 2023. PMID: 37631929 Free PMC article.
Gut Microbiome Disruption Following SARS-CoV-2: A Review.
Righi E, Dalla Vecchia I, Auerbach N, Morra M, Górska A, Sciammarella C, Lambertenghi L, Gentilotti E, Mirandola M, Tacconelli E, Sartor A. Righi E, et al. Among authors: mirandola m. Microorganisms. 2024 Jan 9;12(1):131. doi: 10.3390/microorganisms12010131. Microorganisms. 2024. PMID: 38257958 Free PMC article. Review.
103 results